Search research articles
Contact Us
Filters
Showing results (101-110 of 489) with videos related to
Page
of 49
Sort By:
Cancer Biology & Therapy
|
June 29, 2010
Genetic variant associated with aggressive not indolent prostate cancer
C Tyler Kirkland, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
November 20, 2010
Prostate cancer genomic signature offers prognostic value
Sarah M Troutman, Douglas K Price, William D Figg
American Journal of Public Health
|
July 10, 2001
Remission from drug abuse over a 25-year period: patterns of remission and treatment use
R K Price, N K Risk, E L Spitznagel
Langmuir : the ACS Journal of Surfaces and Colloids
|
June 30, 2012
CryoSEM investigation of latex coatings dried in walled substrates
Kyle K Price, Alon V McCormick, Lorraine F Francis
Cancer Biology & Therapy
|
September 13, 2013
Prostate cancer progression attributed to autonomic nerve development: potential for therapeutic prevention of localized and metastatic disease
Elena V Fernández, Douglas K Price, William D Figg
British Journal of Addiction
|
October 1, 1991
Problem drinking and family history
K D Fletcher, D K Price, C C Cook
Cancer Biology & Therapy
|
December 24, 2014
BET bromodomain inhibitors--a novel epigenetic approach in castration-resistant prostate cancer
Sarah E Lochrin, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
May 15, 2018
Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance
Phoebe A Huang, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
February 13, 2010
Sarcosine as a potential prostate cancer biomarker and therapeutic target
Caitlin E Baum, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
January 30, 2016
Building a hit list for the fight against metastatic castration resistant prostate cancer
Jonathan D Strope, Douglas K Price, William D Figg
Page
of 49
Search research articles
Search
Showing results (101-110 of 489) with videos related to
Sort By:
Page
of 49
Cancer Biology & Therapy
|
June 29, 2010
Genetic variant associated with aggressive not indolent prostate cancer
C Tyler Kirkland, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
November 20, 2010
Prostate cancer genomic signature offers prognostic value
Sarah M Troutman, Douglas K Price, William D Figg
American Journal of Public Health
|
July 10, 2001
Remission from drug abuse over a 25-year period: patterns of remission and treatment use
R K Price, N K Risk, E L Spitznagel
Langmuir : the ACS Journal of Surfaces and Colloids
|
June 30, 2012
CryoSEM investigation of latex coatings dried in walled substrates
Kyle K Price, Alon V McCormick, Lorraine F Francis
Cancer Biology & Therapy
|
September 13, 2013
Prostate cancer progression attributed to autonomic nerve development: potential for therapeutic prevention of localized and metastatic disease
Elena V Fernández, Douglas K Price, William D Figg
British Journal of Addiction
|
October 1, 1991
Problem drinking and family history
K D Fletcher, D K Price, C C Cook
Cancer Biology & Therapy
|
December 24, 2014
BET bromodomain inhibitors--a novel epigenetic approach in castration-resistant prostate cancer
Sarah E Lochrin, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
May 15, 2018
Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance
Phoebe A Huang, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
February 13, 2010
Sarcosine as a potential prostate cancer biomarker and therapeutic target
Caitlin E Baum, Douglas K Price, William D Figg
Cancer Biology & Therapy
|
January 30, 2016
Building a hit list for the fight against metastatic castration resistant prostate cancer
Jonathan D Strope, Douglas K Price, William D Figg
Page
of 49